The many faces of Wnt and pancreatic ductal adenocarcinoma oncogenesis

Cancers

Volumn 3, Issue 3, 2011, Pages 3676-3686

  Weekes, Colin D ^a   Winn, Robert A ^a,b  

^a UNIVERSITY OF COLORADO CANCER CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

catenin; Angiogenesis; Frizzled; K ras; Pancreatic ductal adenocarcinoma; Strom; Wnt

Indexed keywords

BETA CATENIN; CHEMOKINE RECEPTOR CXCR4; FRIZZLED PROTEIN; K RAS PROTEIN; NOTCH RECEPTOR; WNT PROTEIN; WNT5A PROTEIN;

CANCER GROWTH; CANCER INVASION; CANCER STEM CELL; CARCINOGENESIS; CELL HYPOXIA; CELL SURVIVAL; CHRONIC PANCREATITIS; DNA DAMAGE; DRUG RESISTANCE; GENE MUTATION; GENETIC DISORDER; HUMAN; LIGAND BINDING; METASTASIS; NONHUMAN; PANCREAS CARCINOMA; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; TUMOR GROWTH;

EID: 80053219017     PISSN: None     EISSN: 20726694     Source Type: Journal    
DOI: 10.3390/cancers3033676     Document Type: Review

References (66)

1. American Cancer Society. Cancers Facts & Figures 2010; American Cancer Society: Atlanta, GA, USA, 2010; Report No.: 1.
2. Maitra, A.; Hruban, R.H. Pancreatic cancer. Annu. Rev. Pathol. 2008, 3, 157-188.
3. Habbe, N.; Langer, P.; Sina-Frey, M.; Bartsch, D.K. Familial pancreatic cancer syndromes. Endocrinol. Metab. Clin. North Am. 2006, 35, 417-430.
4. Wescott, M.P.; Rustgi, A.K. Pancreatic cancer: Translating lessons from mouse models and hereditary syndromes. Cancer Prev. Res. 2008, 1, 503-506.
5. Wilentz, R.E.; Iacobuzio-Donahue, C.A.; Argani, P.; McCarthy, D.M.; Parsons, J.L.; Yeo, C.J.; Kern, S.E.; Hruban, R.H. Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: Evidence that DPC4 inactivation occurs late in neoplastic progression. Cancer Res. 2000, 60, 2002-2006.
6. Feldmann, G.; Geaty, R.; Hruban, R.H.; Maitra, A. Molecular genetics of pancreatic intraepithelial neoplasia. J. Hepatobiliary Pancreat. Surg. 2007, 14, 224-232.
7. Almoguera, C.; Shibata, D.; Forrester, K.; Martin, J.; Arnheim, N.; Perucho, M. Most human carcinomas of the exocrine pancreas contain mutant c-KRAS genes. Cell 1988, 53, 549-554.
8. Lohr, M.; Kloppel, G.; Maisonneuve, P.; Lowenfels, A.B.; Luttges, J. Frequency of KRAS mutations in pancreatic intraductal epithelial neoplasias associated with pancreatic ductal adenocarcinoma and chronic pancreatitis: A metanalysis. Neoplasia 2005, 7, 17-23.
9. Maitra, A.; Adsay, N.V.; Argani, P.; Iacobuzio-Donahue, C.; De Marzo, A.; Cameron, J.L.; Yeo, C.J.; Hruban, R.H. Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray. Mod. Pathol. 2003, 16, 902-912.
10. Hingorani, S.R.; Petricoin, E.F.; Maitra, A.; Rajapakse, V.; King, C.; Jacobetz, M.A.; Ross, S.; Conrads, T.P.; Veenstra, T.D.; Hitt, B.A. et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell. 2003, 4, 437-450.
11. Tuveson, D.A.; Shaw, A.T.; Willis, N.A.; Silver, D.P.; Jackson, E.L.; Chang, S.; Mercer, K.L.; Grochow, R.; Hock, H.; Crowley, D. et al. Endogenous oncogenic KRASG12D stimulates proliferation and widespread neoplastic and developmental defects. Cancer Cell. 2004, 5, 375-387.
12. Morton, J.P.; Timpsona, P.; Karima, S.A.; Ridgway, R.A.; Athineos, D.; Doyle, B.; Jamieson, N.B.; Oien, K.A.; Lowy, A.M.; Brunton, V.G.; Frame M.C. et al. Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer. Proc. Natl. Acad. Sci. USA 2010, 107, 246-251.
13. Jones, S.; Zhang, X.; Parson, W.D.; Lin, J.C.; Leary, R.J.; Angenendt, P.; Mankoo, P.; Carter, H.; Kamiyama, H.; Jimeno, A. et al. Core signaling pathways in human pancreatic cancer revealed by global genomic analysis. Science. 2008, 321, 1801-1806.
14. Clevers, H. Wnt/β-catenin signaling in development and disease. Cell 2006, 127, 469-480.
15. MacDonald, B.T.; Tamai, K.; He, X. Wnt/β-catenin signaling: components, mechanism and disease. Dev. Cell 2009, 17, 9-26.
16. Grumolato, L.; Guizhong, L.; Mong, P.; Mudbhary, R.; Biswas, R.; Arroyave, R.; Vijayakumar, S.; Economides, A.N.; Aaronson, S.A. Canonical and noncanonical Wnts use a common mechanism to activate completely unrelated coreceptors. Genes Dev. 2010, 24, 2517-2530.
17. Gumbiner, B.M.; McCrea, P.D. Catenins as mediators of the cytoplasmic functions of cadherins. J. Cell Sci. 1993, 17, 155-158.
18. Jou, T.S.; Stewart, D.B.; Stappert, J.; Nelson, W.J.; Marrs, J.A. Genetic and biochemical dissection of protein linkages in the cadherin-catenin complex. Proc. Natl. Acad. Sci. USA 1995, 92, 5067-5071.
19. Kühl, M.; Sheldahl, L.C.; Park, M.; Miller, J.R.; Moon, R.T. The Wnt/Ca2+ pathway: A new vertebrate Wnt signaling pathway takes shape. Trends Genet. 2000, 16, 279-283.
20. Wallingford, J.B.; Mitchell, B. Strange as it may seem: The many links between Wnt signaling, planar cell polarity, and cilia. Genes Dev. 2011, 25, 201-213.
21. Schwartz, A.L.; Malgor, R.; Dickerson, E.; Weeraratna, A.T.; Slominski, A.; Wortsman, J.; Harii, N.; Kohn, A.D.; Moon, R.T.; Schwartz, F.L. et al. Phenylmethimazole decreases toll-like receptor 3 and noncanonical WNT5a expression in pancreatic cancer and melanoma together with tumor cell growth and migration. Clin. Cancer Res. 2009, 15, 4114-4122.
22. Ripka, S.; Konig, A.; Buchholz, M.; Wagner, M.; Sipos, B.; Klöppel, G.; Downward, J.; Gress, T.; Michl, P. WNT5a-target of CUTL1 and potent modulator of tumor cell migration and invasion in pancreatic cancer. Carcinogenesis 2007, 28, 1178-1187.
23. Gerdes, B.; Ramaswamy, A.; Simon, B.; Pietsch, T.; Bastian, D.; Kersting, M.; Moll, R.; Bartsch, D. Analysis of β-catenin gene mutations in pancreatic tumors. Digestion 1999, 60, 544-548.
24. Al-Aynati, M.M.; Radulovich, N.; Riddell, R.H.; Tsao, M.S. Epithelial-cadherin and β-catenin expression changes in pancreatic intraepithelial neoplasia. Clin. Cancer Res. 2004, 10, 1235-1240.
25. Zeng, G.; Germinaro, M.; Micsenyi, A.; Monga, N.K.; Bell, A.; Sood, A.; Malhotra, V.; Sood, N.; Midda, V.; Monga, D.K.; Kokkinakis, D.M.; Monga, S.P. Aberrant Wnt/β-catenin signaling in pancreatic adenocarcinoma. Neoplasia 2006, 8, 279-289.
26. Pasca di Magliano, M.; Biankin, A.V.; Heiser, P.W.; Cano, D.A.; Gutierrez, P.J.; Deramaudt, T.; Segara, D.; Dawson, A.C.; Kench, J.G.; Henshall, S.M.; Sutherland R.L. et al. Common activation of canonical Wnt signaling in pancreatic adenocarcinoma. PLoS one 2007, 2, e1155.
27. Morris, J.P.; Wang, S.C.; Hebrok, M. KRAS, hedgehog, wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma. Nat. Rev. Cancer 2010, 10, 683-695.
28. Kemler, R.; Hierholzer, A.; Kanzler, B.; Kuppig, S.; Hansen, K.; Taketo, M.M.; de Vries, W.N.; Knowles, B.B.; Solter, D. Stabilization of β-catenin in the mouse zygote leads to premature epithelial-mesemchymal transition in the epiblast. Development 2004, 131, 5817-5824.
29. Heiser, P.W.; Lau, J.; Taketo, M.M.; Herrera, P.L.; Hebrok, M. Stabilization of β-catenin impacts pancreas growth. Development 2006, 133, 2023-2032.
30. Strom, A.; Bonal, C.; Ashery-Padan, R.; Hashimoto, N.; Campos, M.L.; Trumpp, A.; Noda, T.; Kido, Y.; Real, F.X.; Thorel, F. et al. Unique mechanisms of growth regulation and tumor suppression upon Apc inactivation I the pancreas. Development 2007, 134, 2719-2725.
31. Heiser, P.W.; Cano, D.W.; Landsman, L.; Kim, G.E.; Kench, J.G.; Klimstra, D.S.; Taketo, M.M.; Biankin, A.V.; Hebrok, M. Stabilization of β-catenin induces pancreas tumor formation. Gastroenterology 2008, 135, 1288-1300.
32. Carriere, C.; Young, A.L.; Gunn, J.R.; Longnecker, D.S.; Korc, M. Acute pancreatitis markedly accelerates pancreatic cancer progression in mice expressing oncogenic Kras. Biochem. Biophys. Res. Commun. 2009, 382, 561-565.
33. Strobel, O.; Dor, Y.; Alsina, J.; Stirman, A.; Lauwers, G.; Trainor, A.; Castillo, C.F.; Warshaw, A.L.; Thayer, S.P. In vivo lineage tracing defines the role of acinar-to-ductal transdifferentiation in inflammatory ductal metaplasia. Gastroenterology 2007, 133, 1999-2009.
34. Siveke, J.T.; Lubeseder-Martellato, C.; Lee, M.; Sipos, B.; Nakhai, H.; Rad, R.; Zimber-Strobl, U.; Strobl, L.J.; Radtke, F.; Klöppel, G.; Schmid, R.M.; Siveke, J.T. Notch signaling is required for exocrine regeneration after acute pancreatitis. Gastroenterology 2008, 134, 544-555.
35. Guerra, C.; Collado, M.; Navas, C.; Schuhmacher, A.J.; Hernández-Porras, I.; Cañamero, M.; Rodriguez-Justo, M.; Serrano, M.; Barbacid, M. Pancreatitis-induced inflammation contributes to pancreatic cancer by inhibiting oncogene-induced senescence. Cancer Cell 2011, 19, 728-739.
36. Ji, B.; Tsou, L.; Wang, H.; Gaiser, S.; Chang, D.Z.; Daniluk, J.; Bi, Y.; Grote, T.; Longnecker, D.S.; Logsdon, C.D. Ras activity levels control the development of pancreatic diseases. Gastroenterology 2009, 137, 1072-1082.
37. Zhu, L.; Shi, G.; Schmidt, C.M.; Hruban, R.H.; Konieczny, S.F. Acinar cells contribute to the molecular heterogeneity of pancreatic intraepithelial neoplasia. Am. J. Pathol. 2007, 171, 263-273.
38. De La Oa, J.-P.; Emersonb, L.L.; Goodmana, J.L.; Froebea, S.C.; Illuma, B.E.; Curtisa, A.B.; Murtaugha, C.L. Notch and Kras reprogram pancreatic acinar cells to ductal intraepithelial neoplasia. Proc. Natl. Acad. Sci. USA 2008, 105, 18907-18912.
39. Crnogorac-Jurcevic, T.; Efthimiou, E.; Capelli, P.; Blaveri, E.; Baron, A.; Terris, B.; Jones, M.; Tyson, K.; Bassi, C.; Scarpa, A. et al. Gene expression profiles of pancreatic cancer and stromal desmoplasia. Oncogene 2001, 20, 7437-7446.
40. Pilarsky, C.; Ammerpohl, O.; Sipos, B.; Dahl, E.; Hartmann, A.; Wellmann, A.; Braunschweig, T.; Löhr, M.; Jesnowski, R.; Friess, H. et al. Activation of Wnt signaling in stroma from pancreatic cancer identified by gene expression profiling. J. Cell. Mol. Med. 2008, 12, 2823-2835.
41. Cejudo-Martin, P.; Johnson, R.S. A new notch in the HIF belt: How hypoxia impacts differentiation. Dev. Cell 2005, 9, 575-576.
42. Pear, W.S.; Simon, D.C. Lasting longer without oxygen: the influence of hypoxia on Notch signaling. Cancer Cell 2005, 8, 435-437.
43. Apelqvist, A.; Li, H.; Sommer, L.; Beatus, P.; Anderson, D.J.; Honjo, T.; Hrabe de Angelis, M.; Lendahl, U.; Edlund, H. Notch signaling controls pancreatic cell differentiation. Nature 1999, 400, 877-881.
44. Jensen, J.; Pederson, E.E.; Galante, P.; Hald, J.; Heller, R.S.; Ishibashi, M.; Kageyama, R.; Guillemot, F.; Serup, P.; Madsen, O.D. Control of endodermal endocrine development by Hes-1. Nat. Genet. 2000, 24, 36-44.
45. Kaidi, A.; Williams, A.C.; Paraskeva, C. Interaction between β-catenin and HIF-1 promotes cellular adaptation to hypoxia. Nat. Cell. Biol. 2007, 9, 210-217.
46. Funato, Y.; Michiue, T.; Asashima, M.; Miki, H. The thioredoxin-related redox-regulating protein nucleoredoxin inhibits Wnt-β-catenin signaling through disheveled. Nat. Cell. Biol. 2006, 8, 501-508.
47. Murtaugh, L.C.; Law, A.C.; Dor, Y.; Melton, D.A. β-catenin is essential for pancreatic acinar but not islet development. Development 2005, 132, 4663-4674.
48. Wells, J.C.; Esni, F.; Boivin, G.P.; Aronow, B.J.; Stuart, W.; Combs, C.; Sklenka, A.; Leach, S.D. Lowy, A.M. Wnt/β-catenin signaling is required for development of the exocrine pancreas. BMC Dev. Biol. 2007, 7, 4.
49. Gomez, G.; Englander, E.W.; Wang, G.; Greeley, G.H., Jr. Increased expression of hypoxiainducible factor-1alpha, p48, and the Notch signaling cascade during acute pancreatitis in mice. Pancreas 2004, 28, 58-64.
50. Wang, Z.; Li, Y.; Kong, D.; Banerjee, S.; Ahmad, A.; Azmi, A.S.; Ali, S.; Abbruzzese, J.L.; Gallick, G.E.; Sarkar, F.H. Acquisition of epithelial-mesenchymal transition phenotype of gemcitabine-resistant pancreatic cancer cells is linked with activation of the notch signaling pathway. Cancer Res. 2009, 69, 2400-2407.
51. Mazur, P.K.; Einwächter, H.; Lee, M.; Sipos, B.; Nakhai, H.; Rad, R.; Zimber-Strobl, U.; Strobl, L.J.; Radtke, F.; Klöppel, G. et al. Notch2 is required for progression of pancreatic intraepithelial neoplasia and development of pancreatic ductal adenocarcinoma. Proc. Natl. Acad. Sci. USA 2010, 107, 13438-13443.
52. Chang, Q.; Jurisica, I.; Do, T.; Hedley, D.W. Hypoxia predicts aggressive growth and spontaneous metastasis formation from orthotopically grown primary xenografts of human pancreatic cancer. Cancer Res. 2011, 71, 3110-3120.
53. Kizaka-Kondoh, S.; Itasaka, S.; Zeng, L.; Tanaka, S.; Zhao, S.; Takahashi, Y.; Keiko, S.; Hirota, K.; Semenza, G.L.; Hiraoka, M. Selective killing of hypoxia-inducible Factor-1-Active cells improves survival in a mouse model of invasive and metastatic pancreatic cancer. Clin. Cancer Res. 2009, 15, 3433-3441.
54. Masckauchan, T.N.; Agalliu, D.; Vorontchikhina, M.; Ahn, A.; Parmalee, N.L.; Li, C.M.; Khoo, A.; Tycko, B.; Brown, A.M.; Kitajewski, J. Wnt5a signaling induces proliferation and survival of endothelial cells in vitro and expression of MMP-1 and Tie-2. Mol. Biol. Cell 2006, 17, 5163-5172.
55. Olive, K.P.; Jacobetz, M.A.; Davidson, C.J.; Gopinathan, A.; McIntyre, D.; Honess, D.; Madhu, B.; Goldgraben, M.A.; Caldwell, M.E.; Allard, D. et al. Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 2009, 324, 1457-1461.
56. Hermann, P.C.; Huber, S.L.; Herrler, T.; Aicher, A.; Ellwart, J.W.; Guba, M.; Bruns, C.J.; Heeschen, C. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 2007, 1, 313-323.
57. Li, C.; Heidt, D.G.; Dalerba, P.; Burant, C.F.; Zhang, L.; Adsay, V.; Wicha, M.; Clarke, M.F.; Simeone, D.M. Identification of pancreatic cancer stem cells. Cancer Res. 2007, 67, 1030-1037.
58. Feldmann, G.; Dhara, S.; Fendrich, V.; Bedja, D.; Beaty, R.; Mullendore, M.; Karikari, C.; Alvarez, H.; Iacobuzio-Donahue, C.; Jimeno, A. et al. Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: A new paradigm for combination therapy in solid cancers. Cancer Res. 2007, 67, 2187-2196.
59. Kim, M.P.; Fleming, J.B.; Wang, H.; Abbruzzese, J.L.; Choi, W.; Kopetz, S.; McConkey, D.J.; Evans, D.B.; Gallick, G.E. ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma. PLoS one 2011, 6, e20636.
60. Ishizawa, K.; Rasheed, Z.A.; Karisch, R.; Wang, Q.; Kowalski, J.; Susky, E.; Pereira, K.; Karamboulas, C.; Moghal, N.; Rajeshkumar, N.V.; Hidalgo, M. et al. Tumor-initiating cells are rare in many human tumors. Cell Stem Cell 2010, 7, 279-282.
61. Jimeno, A.; Feldmann, G.; Suárez-Gauthier, A.; Rasheed, Z.; Solomon, A.; Zou, G.M.; Rubio-Viqueira, B.; García-García, E.; López-Ríos, F.; Matsui, W. et al. A direct pancreatic cancer xenograft model as a platform for cancer stem cell therapeutic development. Mol. Cancer Ther. 2009, 8, 310-314.
62. Kwon, C.; Cheng, P.; King, I.N.; Andersen, P.; Shenje, L.; Nigam, V.; Srivastava, D. Notch post-translationally regulates β-catenin protein in stem and progenitor cells. Nat. Cell Biol. 2011, doi:10.1038/ncb2313.
63. Wang, Z.; Ma, Q.; Liu, Q.; Yu, H.; Zhao, L.; Shen, S.; Yao, J. Blockade of SDF-1/CXCR4 signalling inhibits pancreatic cancer progression in vitro via inactivation of canonical Wnt pathway. Br. J. Cancer 2008, 99, 1695-1703.
64. Singh, S.; Srivastava, S.K.; Bhardwaj, A.; Owen, L.B.; Singh, A.P. CXCL12-CXCR4 signalling axis confers gemcitabine resistance to pancreatic cancer cells: A novel target for therapy. Br. J. Cancer 2010, 103, 1671-1679.
65. Shah, A.N.; Summy, J.M.; Zhang, J.; Park, S.I.; Parikh, N.U.; Gallick, G.E. Development and characterization of gemcitabine-resistant pancreatic tumor cells. Ann. Surg. Oncol. 2007, 14, 3629-3637.
66. Danilkovitch-Miagkova, A.; Miagkov, A.; Skeel, A.; Nakaigawa, N.; Zbar, B.; Leonard, E.J. Oncogenic mutants of RON and MET receptor tyrosine kinases cause activation of the beta-catenin pathway. Mol. Cell Biol. 2001, 21, 5857-5868.